Azitra Inc
Last updated September 27, 2026
Organization details
- Legal name
- Azitra Inc
- Ownership
- Public
- Status
- Active
- Ticker symbol
- AZTR
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001701478
Board of directors
-
Andrew McClary · DirectorSince 2023
-
Barbara Ryan · DirectorSince 2023
-
Francisco D. Salva · Director · President and CEOSince 2023
-
John R. Schroer · DirectorSince 2023
-
Travis Whitfill · Director · Chief Operating OfficerSince 2023
Chief executives
Francisco D. Salva
· President and CEO
Since June 2023
Board connections
2 of this board's directors also sit on 4 other boards.
- via Travis Whitfill
- via Barbara Ryan
- via Barbara Ryan
- via Barbara Ryan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Francisco D. Salva Director, Officer (President and CEO) | Derivative conversion | +4,064,050 | — | — |
| Mar 29, 2024 | Staskey Norm Officer (Chief Financial Officer) | Open-market purchase | +47,600 | $0.21 | $9,996 |
| Feb 13, 2024 | Travis Whitfill Director, Officer (Chief Operating Officer) | Open-market purchase | +15,000 | $0.30 | $4,500 |
| Feb 13, 2024 | Staskey Norm Officer (Chief Financial Officer) | Open-market purchase | +3,300 | $0.30 | $990 |
| Feb 13, 2024 | Francisco D. Salva Director, Officer (President and CEO) | Open-market purchase | +333,300 | $0.30 | $99,990 |
| Jun 21, 2023 | Andrew McClary Director | Derivative conversion | +42,347 | — | — |
| Jun 21, 2023 | Cavu Advisors, LLC 10% owner | Open-market sale | −77,953 | — | — |
| Jun 21, 2023 | BIOS Fund III NT, LP 10% owner | Open-market sale | −77,953 | — | — |
| Jun 21, 2023 | Francisco D. Salva Director, Officer (President and CEO) | Grant or award | +5,000 | $5.00 | $25,000 |
| Jun 21, 2023 | Travis Whitfill Director, Officer (Chief Operating Officer) | Grant or award | +250 | $5.00 | $1,250 |
| Jun 21, 2023 | Bayer World Investments B.V. 10% owner | Derivative conversion | +1,307,401 | — | — |
| Jun 21, 2023 | Andrew McClary Director | Derivative conversion | +16,975 | — | — |
| Jun 21, 2023 | Cavu Advisors, LLC 10% owner | Open-market purchase | +197,701 | — | — |
| Jun 21, 2023 | BIOS Fund III NT, LP 10% owner | Open-market purchase | +197,701 | — | — |
| Jun 21, 2023 | Cavu Advisors, LLC 10% owner | Open-market purchase | +69,880 | $5.00 | $349,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.